Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and ...

Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that sometimes cause impaired decision-making and poor ... Some Diabetes Drugs Tied to ...

A joint research team from the LKS Faculty of Medicine (HKUMed) and the Faculty of Science at the University of Hong Kong has uncovered an unexpected interaction between chemotherapeutic agents and a ...

The US Food and Drug Administration (FDA) rejected three prior regulatory applications before granting approval.

People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.

Irritable bowel syndrome (IBS) is a common digestive disorder that affects the intestine, causing symptoms such as abdominal pain, bloating, gas, and changes in bowel habits, including diarrhea, ...

I would have walked hundreds of miles blindfolded. I would have slayed a dragon and collected its blood in a vial made from a ...

(IKT), a biopharmaceutical company with a market capitalization of $189.48 million, has announced the halting of further development of its Parkinson's disease drug, risvodetinib, following the ...

Always take the Xadago dosage your doctor prescribes. Xadago is a prescription drug used to help treat Parkinson’s disease in adults. It’s prescribed for use during “off periods.” ...

Jan. 14, 2025 — There may be a link between hearing impairment and an increased risk of developing Parkinson's according to new research. This is one of the first studies to examine whether ...

“It is with profound regret that, due to performance issues associated with my recently diagnosed Parkinsonism, I find that I must bow out of my role with the Eagles while I can still do so ...